Samuel C. Blackman, HEAD OF R&D at Day One Biopharmaceuticals, Inc. (DAWN), sold 22,490 shares at $16.03 ($361K) on 2024-11-07, disclosed to the SEC on 2024-11-08.
Scheduled sale ($361k) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.03 | 11,245 | $180K | 50.0% |
| 2 | $16.03 | 11,245 | $180K | 50.0% |
| Total | $16.03 avg | 22,490 | $361K | 100% |
| Filing → |
| DAWN | SELL | 2024-11-12 | $751K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |
| DAWN | SELL | 2024-09-12 | $427K | — | Filing → |